UroGen Pharma Ltd. (URGN) Rose 5.42% or 1.95 To Price $37.9 On Wednesday


UroGen Pharma Ltd. (URGN) rose 5.42% or 1.95 to $37.9. It is near to 84910 shares traded, which is 84.29% compare to the average total volume 100734. The market cap of URGN is $786.88 million. The year to date change is -13.81%. The 52 week price range is from $34.61 to $69.57. Price of URGN have changed -3.00% during last week. It have changed -2.68% over last month, -9.81% over last 3 months, -6.48% over last 6 months and -35.83% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 38.05. It is 0.40% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for URGN is 43.60. It is 15.04% above current price. The 52-week High is 69.57. It is 83.56% from the current price. The 52-week Low is 34.61. It is -8.68% from current price.

There are some statistics of URGN. It is has market cap $786.88 million. The share outstanding is 20.76 million. The average volume is 100734. The percent of top 15 Institution holding is 60.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -97.20%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -86.03%.


Tags:

Share this post